150 related articles for article (PubMed ID: 16568082)
41. Inhibition of prostate tumor angiogenesis by the tumor suppressor CEACAM1.
Volpert O; Luo W; Liu TJ; Estrera VT; Logothetis C; Lin SH
J Biol Chem; 2002 Sep; 277(38):35696-702. PubMed ID: 12122002
[TBL] [Abstract][Full Text] [Related]
42. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
Ngan BY; Forte V; Campisi P
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446
[TBL] [Abstract][Full Text] [Related]
43. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
Zeng Y; Opeskin K; Goad J; Williams ED
Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
[TBL] [Abstract][Full Text] [Related]
44. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
[TBL] [Abstract][Full Text] [Related]
45. CEACAM1 inhibits cell-matrix adhesion and promotes cell migration through regulating the expression of N-cadherin.
Liu J; Di G; Wu CT; Hu X; Duan H
Biochem Biophys Res Commun; 2013 Jan; 430(2):598-603. PubMed ID: 23219815
[TBL] [Abstract][Full Text] [Related]
46. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells.
Yano A; Fujii Y; Iwai A; Kageyama Y; Kihara K
Clin Cancer Res; 2006 May; 12(10):3003-9. PubMed ID: 16707595
[TBL] [Abstract][Full Text] [Related]
47. Contribution of intestinal epithelial cells to innate immunity of the human gut--studies on polarized monolayers of colon carcinoma cells.
Ou G; Baranov V; Lundmark E; Hammarström S; Hammarström ML
Scand J Immunol; 2009 Feb; 69(2):150-61. PubMed ID: 19170965
[TBL] [Abstract][Full Text] [Related]
48. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer.
Dango S; Sienel W; Schreiber M; Stremmel C; Kirschbaum A; Pantel K; Passlick B
Lung Cancer; 2008 Jun; 60(3):426-33. PubMed ID: 18215438
[TBL] [Abstract][Full Text] [Related]
49. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
Xu Z; Maiti D; Kisiel W; Duh EJ
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2819-25. PubMed ID: 17023682
[TBL] [Abstract][Full Text] [Related]
50. Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer.
Sonoda K; Miyamoto S; Yamazaki A; Kobayashi H; Nakashima M; Mekada E; Wake N
Cancer; 2007 Nov; 110(9):1979-90. PubMed ID: 17849467
[TBL] [Abstract][Full Text] [Related]
51. Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression predicts metachronous pulmonary metastasis and poor survival in patients with hepatoblastoma.
Tsukada M; Wakai T; Matsuda Y; Korita PV; Shirai Y; Ajioka Y; Hatakeyama K; Kubota M
J Pediatr Surg; 2009 Aug; 44(8):1522-8. PubMed ID: 19635299
[TBL] [Abstract][Full Text] [Related]
52. [CEACAM1 as a central modulator of metabolism, tumor progression, angiogenesis and immunity].
Nouvion AL; Beauchemin N
Med Sci (Paris); 2009 Mar; 25(3):247-52. PubMed ID: 19361387
[TBL] [Abstract][Full Text] [Related]
53. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
54. CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium.
Zalzali H; Naudin C; Bastide P; Quittau-Prévostel C; Yaghi C; Poulat F; Jay P; Blache P
Oncogene; 2008 Nov; 27(56):7131-8. PubMed ID: 18794798
[TBL] [Abstract][Full Text] [Related]
55. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis.
Phan D; Cheng CJ; Galfione M; Vakar-Lopez F; Tunstead J; Thompson NE; Burgess RR; Najjar SM; Yu-Lee LY; Lin SH
Cancer Res; 2004 May; 64(9):3072-8. PubMed ID: 15126343
[TBL] [Abstract][Full Text] [Related]
56. Pro-angiogenic properties of orosomucoid (ORM).
Irmak S; Oliveira-Ferrer L; Singer BB; Ergün S; Tilki D
Exp Cell Res; 2009 Nov; 315(18):3201-9. PubMed ID: 19651122
[TBL] [Abstract][Full Text] [Related]
57. CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation.
Gerstel D; Wegwitz F; Jannasch K; Ludewig P; Scheike K; Alves F; Beauchemin N; Deppert W; Wagener C; Horst AK
Oncogene; 2011 Oct; 30(41):4275-88. PubMed ID: 21532628
[TBL] [Abstract][Full Text] [Related]
58. CEACAM1 distribution and it's effects on angiogenesis and lymphangiogenesis in oral carcinoma.
Zhou CJ; Qu X; Yang YM; Wang FF; Dong ZQ; Wang CQ; Zhang XY; Liu GX; Wei FC; Sun SZ
Oral Oncol; 2009 Oct; 45(10):883-6. PubMed ID: 19442569
[TBL] [Abstract][Full Text] [Related]
59. The human tumor suppressor CEACAM1 modulates apoptosis and is implicated in early colorectal tumorigenesis.
Nittka S; Günther J; Ebisch C; Erbersdobler A; Neumaier M
Oncogene; 2004 Dec; 23(58):9306-13. PubMed ID: 15568039
[TBL] [Abstract][Full Text] [Related]
60. CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases.
Liu W; Wei W; Winer D; Bamberger AM; Bamberger C; Wagener C; Ezzat S; Asa SL
Oncogene; 2007 Apr; 26(19):2747-58. PubMed ID: 17057731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
